Population pharmacokinetics and genetics of oral meltdose tacrolimus (Envarsus®) in stable adult liver transplant recipients.
Sign Up to like & getrecommendations! Published in 2021 at "British journal of clinical pharmacology"
DOI: 10.1111/bcp.14842
Abstract: INTRODUCTION Meltdose tacrolimus (Envarsus®) is marketed as a formulation with a more consistent exposure. Due to the narrow therapeutic window, therapeutic drug monitoring is essential to maintain adequate exposure. The primary objective of this study… read more here.
Keywords: envarsus; genetics; liver transplant; meltdose tacrolimus ... See more keywords
Envarsus XR® pharmacokinetics in adolescents post‐kidney transplantation – A pilot study
Sign Up to like & getrecommendations! Published in 2023 at "Pediatric Transplantation"
DOI: 10.1111/petr.14480
Abstract: Envarsus XR® (LCPT), a once daily dosage formulation of tacrolimus, is an FDA‐approved medication in adult renal transplant recipients (RTRs). There are limited data on its pharmacokinetics (PK) in adolescent RTRs. We report here the… read more here.
Keywords: post kidney; adolescents post; envarsus; transplantation ... See more keywords
Intestinal Permeability in Patients Early after Kidney Transplantation Treated with Two Different Formulations of Once-Daily Tacrolimus
Sign Up to like & getrecommendations! Published in 2023 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms24098344
Abstract: Adequate tacrolimus blood exposure is crucial in the early post-renal transplant period and a gut epithelial barrier integrity may play a role. We prospectively investigated several markers of intestinal permeability in recent kidney transplant recipients… read more here.
Keywords: intestinal permeability; kidney; envarsus; daily tacrolimus ... See more keywords